WWS
DGX icon

Wellington Wealth Strategies’s Quest Diagnostics DGX Stock Holding History

Wellington Wealth Strategies’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-1,314
Closed -$203K – 77
2024
Q3 		$203K Sell
1,314
-835
-39% -$125K 0.15% 70
2024
Q2 		$294K Buy
+2,149
New +$294K 1.23% 24
2024
Q1 		– Sell
-2,457
Closed -$339K – 162
2023
Q4 		$339K Buy
+2,457
New +$323K 0.29% 58
2020
Q4 		$339K Buy
+2,457
New +$300K 0.29% 59

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return
Grantham, Mayo, Van Otterloo & Co (GMO)
Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $39.1B AUM 28.69% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Wellington Wealth Strategies's DGX Position: Q4 2024 in Review

Wellington Wealth Strategies sold out of Quest Diagnostics (DGX) in Q4 2024, closing a stake of 1,314 shares — an estimated $203K sold.

Wellington Wealth Strategies first reported a position in DGX in Q4 2020 and held it in 4 quarters. The position peaked at $339K in Q4 2023. 895 funds tracked by Wall St. Rank hold DGX as of Q4 2024.

  • Wellington Wealth Strategies reported no remaining Quest Diagnostics position as of Q4 2024 after selling out during the quarter.
  • Wellington Wealth Strategies sold 1,314 Quest Diagnostics shares in Q4 2024, an estimated $203K.
  • Wellington Wealth Strategies first reported a position in Quest Diagnostics in Q4 2020 and held it in 4 quarters.
  • Wellington Wealth Strategies's Quest Diagnostics position peaked at $339K in Q4 2023.
  • 895 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2024.

Based on Wellington Wealth Strategies's 13F filing for Q4 2024, filed 14 Feb 2025.